Introducing a full validated analytical procedure as an official compendial method for fentanyl transdermal patches

Daru

Volumn 13, Issue 2, 2005, Pages 46-51

  Mehdizadeh, Amir ^a,b   Toliyat, Tayebeh ^a   Rouini, Mohammad Reza ^a   Kobarfard, Farzad ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Hakim Pharmaceutical Company   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug release; Fentanyl; Method validation; Transdermal patches

Indexed keywords

FENTANYL;

ANALYTIC METHOD; ARTICLE; CLINICAL LABORATORY; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; STANDARD;

EID: 24744434599     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Barry WB. Novel mechanism and devices to enable successful transdermal delivery. Eur J Pharm Sci 2001; 14: 101-114.
2. Choi HS. Quantitative analysis of fentanyl in rat plasma by gas chromatography with nitrogen-phosphorus detection. J Chrom B 2001; 765: 63-69.
3. Portier EJG, Blok K, Butter JJ. Simultaneous determination of fentanyl and midazolam using high performance liquid chromatography with ultraviolet detection. J Chrom B 1999; 723: 313-318.
4. Yuansheng L, Yutian WU, Jing Z. Capillary GC Determination of fentanyl and midiazolam in human plasma. Mic Chem J 1996; 53: 130-136.
5. United States Pharmacopeia 27, Rockville, MD. 2004.
6. International Conference on Harmonization, ICH. Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures. Geneva 1996.
7. US FDA, Technical Review Guide Validation of Chromatographic Methods, Center for Drug Evaluation and Research (CDER), Rockville, MD 1998.
8. General Chapter 〈1225〉, Validation of compendial methods. United States Pharmacopeia 27, Rockville, MD 2004.
9. McDowall RD. The role of laboratory information management systems (LIMS) in analytical method validation. Anal Chim Acta 1999; 391: 149-158.
10. Ivanoic D, Medenica M, Malenovic A, Jancic B. Validation of the RP-HPLC method for analysis of hydrochlorothiazide and captopril in tablets. Accred. Qual. Assur. 2004; 9: 76-81.
11. Huber L. Qualification of high performance liquid Chromatography systems. J BioPharm 1998; 11: 41-44.
12. Winslow PA, Meyer RF. Defining a master plan for the validation of analytical methods. J Valid Tech 1997; 14: 361-367.
13. Hokanson GC. A life cycle approach to the validation of analytical methods during pharmaceutical product development, part I: The initial validation process, Pharm Tech 1994; 21: 118-130.
14. Renger H, Fischer J M, Funk W. Validation of analytical procedures in pharmaceutical analytical chemistry: HPTLC assay of theophylline in an effervescent tablet. J Planar Chrom 1995; 8: 269-278.
15. Burgess C. Development and validation of analytical methods. Anal Chem Acta 1997; 338: 163-165.
16. Ellison SLR, Williams A. Measurement uncertainty and its implications for collaborative study method validation and method performance parameters. Accred Qual Assur 1998; 3: 6-10.
17. van Zoonen P, Hoogerbrugge R, Gort SM, van de Wiel H. Some practical examples of method validation in the analytical laboratory. Trend Anal Chem 1999; 18: 584-593.
18. Lauwaars M. Methods validation: AOAC's three validation systems. Accred Qual Assur 1998; 3: 32-35.